Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.94% | 88.65 | 1.3% | $803.98m | |
| AMGN | Amgen Inc. | -0.76% | 185.50 | 1.2% | $628.99m | |
| GILD | Gilead Sciences, Inc. | -2.14% | 65.55 | 0.9% | $482.29m | |
| BIIB | Biogen Inc. | -4.17% | 321.17 | 1.3% | $427.44m | |
| ILMN | Illumina, Inc. | -1.77% | 296.88 | 3.5% | $311.35m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.92% | 418.62 | 2.6% | $290.18m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.55% | 183.06 | 1.9% | $253.58m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.76% | 127.55 | 2.0% | $219.68m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.87% | 136.54 | 15.4% | $152.33m | |
| A | Agilent Technologies, Inc. | -0.83% | 77.91 | 1.6% | $150.84m | |
| EXAS | Exact Sciences Corporation | -0.42% | 83.28 | 25.3% | $132.28m | |
| INCY | Incyte Corporation | -0.49% | 83.33 | 2.5% | $111.93m | |
| ARRY | Array BioPharma Inc. | -1.99% | 22.71 | 8.2% | $108.01m | |
| EXEL | Exelixis, Inc. | -0.09% | 21.22 | 6.4% | $82.07m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.58% | 77.31 | 5.1% | $77.22m |
Company Profile
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.